Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
4
80%
Ph phase_2
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
1(20.0%)
Phase 4Post-market surveillance
4(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Completed2
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (20.0%)
Phase 44 (80.0%)

Trials by Status

completed240%
recruiting240%
not_yet_recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
not_yet_recruitingphase_2

Prediction and Prevention of Bloodstream Infections After Kidney Transplantation

NCT07407673
recruitingphase_4

Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care

NCT07236944
completedphase_4

Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.

NCT04959331
recruitingphase_4

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

NCT06709196
completedphase_4

Treating Pyelonephritis an Urosepsis With Pivmecillinam

NCT03282006

Clinical Trials (5)

Showing 5 of 5 trials
NCT07407673Phase 2

Prediction and Prevention of Bloodstream Infections After Kidney Transplantation

Not Yet Recruiting
NCT07236944Phase 4

Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care

Recruiting
NCT04959331Phase 4

Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.

Completed
NCT06709196Phase 4

Clinical Trial Testing Whether Targeted Antibiotic Prophylaxis Can Reduce Infections After Cystectomy Compared to Empiric Prophylaxis

Recruiting
NCT03282006Phase 4

Treating Pyelonephritis an Urosepsis With Pivmecillinam

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5